Shandong Chengchuang Blue Sea Pharmaceutical Technology Co., LTD.

Apalutamide Tablets are oral non‑steroidal anti‑androgens and androgen receptor inhibitors, indicated for adult male patients with non‑metastatic castration‑resistant prostate cancer (nmCRPC) and metastatic castration‑sensitive prostate cancer (mCSPC). Our apalutamide API is self‑manufactured, and the finished tablets have completed bioequivalence (BE) study in China. We can supply qualified finished dosage forms, offer technology transfer, or discuss other flexible cooperation models. Please contact us for detailed documents, specifications and cooperation terms.